<?xml version="1.0" encoding="UTF-8"?>
<ref id="B54-viruses-12-00023">
 <label>54.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Goodman</surname>
    <given-names>L.B.</given-names>
   </name>
   <name>
    <surname>Wagner</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Flaminio</surname>
    <given-names>M.J.</given-names>
   </name>
   <name>
    <surname>Sussman</surname>
    <given-names>K.H.</given-names>
   </name>
   <name>
    <surname>Metzger</surname>
    <given-names>S.M.</given-names>
   </name>
   <name>
    <surname>Holland</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Osterrieder</surname>
    <given-names>N.</given-names>
   </name>
  </person-group>
  <article-title>Comparison of the efficacy of inactivated combination and modified-live virus vaccines against challenge infection with neuropathogenic equine herpesvirus type 1 (EHV-1)</article-title>
  <source>Vaccine</source>
  <year>2006</year>
  <volume>24</volume>
  <fpage>3636</fpage>
  <lpage>3645</lpage>
  <pub-id pub-id-type="doi">10.1016/j.vaccine.2006.01.062</pub-id>
  <?supplied-pmid 16513225?>
  <pub-id pub-id-type="pmid">16513225</pub-id>
 </element-citation>
</ref>
